Page 105 - 南京医科大学自然版
P. 105
第45卷第7期 李天时,朱 轶,张忠满,等. 革兰阴性杆菌血流感染的脓毒症相关性脑病患者临床特征分析[J].
2025年7月 南京医科大学学报(自然科学版),2025,45(7):1001-1006,1034 ·1003 ·
-
G bacillus bloodstream infection
in adult patients with sepsis
(n=336) 129 patients were excluded:
① Central nervous system infection(n=12)
② Acute hepatic or renal failure(n=29)
Included patients ③ Poisoning(n=5)
(n=207) ④ Previous neurological deficits(n=59)
⑤ The data are severely missing(n=24)
SAE group non⁃SAE group
(n=92) (n=115)
图1 研究人群纳排流程
Figure 1 Flowchart of study population inclusion and exclusion process
表1 SAE组与无SAE组患者的基线特征分析
Table 1 Baseline characteristics analysis of patients in the SAE and non⁃SAE group
Variable Total(n=207) SAE(n=92) non⁃SAE(n=115) P
Age[years,M(P25,P75 )] 66(55,75) 66(53,74) 66(55,75) 0.702
Male[n(%)] 125(60.4) 62(67.4) 63(54.8) 0.065
BMI[kg/m ,M(P25,P75 )] 23.2(21,25.4) 24.1(21.3,26.0) 23(20.8,25.2) 0.130
2
Bacillus[n(%)] 0.126
Escherichia coli 73(37.7) 27(29.3) 45(40.0)
Klebsiella pneumoniae 71(30.9) 31(33.7) 40(34.8)
ESBLs 48(23.7) 27(29.3) 21(18.3)
CRE 13(5.8) 7(7.6) 6(5.2)
Others 2(1.9) 0(0) 2(1.7)
Primary infection[n(%)] 0.004
Urinary system 55(26.5) 22(23.9) 33(28.7)
Digestive system 84(40.5) 29(31.5) 55(47.8)
Respiratory system 11(5.3) 9(9.8) 2(1.7)
Other 26(12.5) 17(18.5) 9(7.8)
Undetermined 31(14.9) 15(16.3) 16(13.9)
Co⁃morbidity[n(%)]
Hypertension 99(47.8) 47(51.1) 52(45.2) 0.401
DM 87(42.0) 48(52.2) 39(33.9) 0.008
Stroke 32(15.4) 19(20.7) 13(11.3) 0.065
CHD 30(14.4) 15(16.3) 15(13.0) 0.508
Tumour 47(22.7) 21(22.8) 26(22.6) 0.970
Immunosuppressants 36(17.3) 13(14.1) 23(20.0) 0.268
Catheterization 50(24.1) 30(32.6) 20(17.4) 0.011
Chronic renal disease 6(2.8) 3(3.3) 3(2.6) 0.548
Chronic hepatic disease 13(6.2) 6(6.5) 7(6.1) 0.898
SOFA score[M(P25,P75 )] 6(3,10) 10(6,13) 4(2,6) <0.001
PBS score[M(P25,P75 )] 2(0,4) 5(3,8) 2(1,2) <0.001
Life support therapy[n(%)]
MV 48(23.1) 45(48.9) 3(2.6) <0.001
CRRT 30(14.4) 26(28.3) 4(3.5) <0.001
Vasoactive agent 68(32.8) 50(54.3) 18(15.7) <0.001
30⁃day survival rate[n(%)] 176(85.0) 64(69.6) 112(97.4) <0.001
SAE:sepsis associated encephalopathy;BMI:body mass index;ESBLs:extended spectrum beta⁃lactamases;CRE:carbapenem⁃resistant enterobac⁃
teriaceae;DM:diabetes mellitus;CHD:coronary heart disease;SOFA score:sepsis⁃related organ failure assessment score;PBS score:the Pitt bacteremia
score;MV:mechanical ventilation;CRRT:continuous renal replacement therapy.

